First Financial Equity Corporation’s Biogen BIIB Stock Holding History

First Financial Equity Corporation’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$347K	Buy	+1,286	New	+$364K	0.06%	289

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Financial Equity Corporation's BIIB Position: Q1 2017 in Review

First Financial Equity Corporation opened a new position in Biogen (BIIB) in Q1 2017: 1,286 shares worth $347K. The stake represents 0.06% of the portfolio and ranks #289 among its holdings.

1,019 funds tracked by Wall St. Rank hold BIIB as of Q1 2017.

First Financial Equity Corporation held 1,286 shares of Biogen worth $347K as of Q1 2017.
Biogen was a new First Financial Equity Corporation position in Q1 2017.
Biogen made up 0.06% of First Financial Equity Corporation's portfolio in Q1 2017, its #289 holding.
1,019 funds tracked by Wall St. Rank held Biogen as of Q1 2017.

Based on First Financial Equity Corporation's 13F filing for Q1 2017, filed 16 May 2017.